ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,615.35
      0.55%
      US Tech 100
      19,804.00
      0.64%
      Dow Jones
      40,000.90
      0.62%
      Brent Oil
      84.57
      0.00%
      Bitcoin
      60,230.84
      1.68%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Europe
      5. EU
      6. Galapagos (GLPG)

      7. Galapagos (GLPG) News

      GLPG

      Galapagos (GLPG)

      Galapagos
      		Date:
      Sort by:
       Showing the most relevant articles for your search:EU:GLPG
      DateTimeSourceHeadlineSymbolCompany
      03/23/20175:02PMGlobeNewswire Inc.Publication of the annual report and invitation to the annual and extraordinary shareholders' meetingsEU:GLPGGalapagos
      03/23/20175:02PMGlobeNewswire Inc.Publication of the annual report and invitation to the annual and extraordinary shareholders' meetingsEU:GLPGGalapagos
      03/22/20172:31AMGlobeNewswire Inc.Galapagos initiates Phase 1 study with novel CF potentiator GLPG3067EU:GLPGGalapagos
      03/22/20172:31AMGlobeNewswire Inc.Galapagos initiates Phase 1 study with novel CF potentiator GLPG3067EU:GLPGGalapagos
      03/10/20171:31AMGlobeNewswire Inc.New Phase 2 studies with filgotinib in small bowel and fistulizing Crohn's diseaseEU:GLPGGalapagos
      03/10/20171:31AMGlobeNewswire Inc.New Phase 2 studies with filgotinib in small bowel and fistulizing Crohn's diseaseEU:GLPGGalapagos
      02/23/20174:01PMGlobeNewswire Inc.Galapagos reports strong financial results and newsflow-rich pipelineEU:GLPGGalapagos
      02/23/20174:01PMGlobeNewswire Inc.Galapagos reports strong financial results and newsflow-rich pipelineEU:GLPGGalapagos
      02/23/20174:01PMGlobeNewswire Inc.Galapagos doses first healthy volunteer with CF combo GLPG2222 and GLPG2451EU:GLPGGalapagos
      02/23/20174:01PMGlobeNewswire Inc.Galapagos doses first healthy volunteer with CF combo GLPG2222 and GLPG2451EU:GLPGGalapagos
      02/01/20174:02PMGlobeNewswire Inc.Galapagos doses first patient with novel CF corrector GLPG2222EU:GLPGGalapagos
      02/01/20174:02PMGlobeNewswire Inc.Galapagos doses first patient with novel CF corrector GLPG2222EU:GLPGGalapagos
      01/20/20174:04PMGlobeNewswire Inc.Galapagos creates new warrant planEU:GLPGGalapagos
      01/20/20174:04PMGlobeNewswire Inc.Galapagos creates new warrant planEU:GLPGGalapagos
      01/17/20174:05PMGlobeNewswire Inc.Dr. Walid Abi-Saab joins Galapagos as Chief Medical OfficerEU:GLPGGalapagos
      01/17/20174:05PMGlobeNewswire Inc.Dr. Walid Abi-Saab joins Galapagos as Chief Medical OfficerEU:GLPGGalapagos
      12/20/20164:07PMGlobeNewswire Inc.SAPHIRA 1 topline shows competitive clinical results in G551D patientsEU:GLPGGalapagos
      12/20/20164:07PMGlobeNewswire Inc.SAPHIRA 1 topline shows competitive clinical results in G551D patientsEU:GLPGGalapagos
      12/15/20164:36AMGlobeNewswire Inc.The Lancet publishes FITZROY study results with filgotinib in Crohn's diseaseEU:GLPGGalapagos
      12/15/20164:36AMGlobeNewswire Inc.The Lancet publishes FITZROY study results with filgotinib in Crohn's diseaseEU:GLPGGalapagos
      12/08/20164:03PMGlobeNewswire Inc.Start Phase 2b/3 study with filgotinib in ulcerative colitisEU:GLPGGalapagos
      12/08/20164:03PMGlobeNewswire Inc.Start Phase 2b/3 study with filgotinib in ulcerative colitisEU:GLPGGalapagos
      11/29/20164:03PMGlobeNewswire Inc.Galapagos increases share capital through warrant exercisesEU:GLPGGalapagos
      11/29/20164:03PMGlobeNewswire Inc.Galapagos increases share capital through warrant exercisesEU:GLPGGalapagos
      11/28/20164:04PMGlobeNewswire Inc.Galapagos initiates Phase 1 study with cystic fibrosis drug GLPG2737EU:GLPGGalapagos
      11/28/20164:04PMGlobeNewswire Inc.Galapagos initiates Phase 1 study with cystic fibrosis drug GLPG2737EU:GLPGGalapagos
      11/24/20161:35AMGlobeNewswire Inc.Galapagos selected for Stoxx Europe 600 IndexEU:GLPGGalapagos
      11/24/20161:35AMGlobeNewswire Inc.Galapagos selected for Stoxx Europe 600 IndexEU:GLPGGalapagos
      11/22/20164:04PMGlobeNewswire Inc.Phase 3 study with filgotinib initiated in Crohn's diseaseEU:GLPGGalapagos
      11/22/20164:04PMGlobeNewswire Inc.Phase 3 study with filgotinib initiated in Crohn's diseaseEU:GLPGGalapagos
       Showing the most relevant articles for your search:EU:GLPG